The effect of Beta Glucan and both of Beta Glucan and Lactobacillus Rhamnosus GG on immune system , nutritional status and side effects of chemptherapy in breast cancer patients
Not Applicable
- Conditions
- Breast Cancer.Malignant Neoplasm of Breast
- Registration Number
- IRCT201212172017N10
- Lead Sponsor
- Hematology Oncology Research Center, Tabbriz University of medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
physician definitive diagnosis of breast cancer; receiving chemotherapy; the ability to drink at least 100 ml of water per day; life expectancy and survival at least 3 months; no allergies to molds and yeasts; adequate bone marrow function; proper function of kidney; absence of other acute medical conditions and aged 20 years and older. Exclusion criteria: patient reluctance to participate in the study; pregnant women; lactating women and existence the acute medical illness.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of Immune System. Timepoint: Immediately After the Intervention. Method of measurement: CBC,CD4,CD45,IL-4,IL-12.
- Secondary Outcome Measures
Name Time Method Improved Chemotherapy Side Effects. Timepoint: Immediately After the Intervention. Method of measurement: Questionnair.;Improved Nutrition Status. Timepoint: Immediately After the Intervention. Method of measurement: Anthropometric Assessment.